Niche management allows
both depth and breadth

Our investment team consists of specialist portfolio managers who are responsible for their own sub-sectors within the healthcare sector: pharmaceuticals, biotech, medical technology and healthcare services. This specialized approach is crucial since the four sub-sectors have widely different characteristics and drivers, each with a high degree of complexity.

Investment team

Henrik Rhenman
Founding Partner / Chief Investment Officer

Employed at Rhenman & Partners since 2008. Over 25 years of experience in portfolio management. Education: Biochemist, Royal Institute of Technology, B.Sc., Stockholm School of Economics.

Kaspar Hållsten
Portolio Manager – Medical Technology

Employed at Rhenman & Partners since 2017. Education: Business Administration, Finance, B.Sc., Stockholm Business School.

Amennai Beyeen, PhD
Portfolio Manager – Biopharma

Employed at Rhenman & Partners since 2023. 15 years of experience in medical positions within the life science industry. Education: M.Sc. Biomedicine and a PhD, Karolinska Institute.

Camilla Oxhamre Cruse, PhD, MBA
Portfolio Manager – Biopharma

Employed at Rhenman & Partners since 2023. 15 years of experience in medical positions within the life science industry. Education: M.Sc. Biomedicine and a PhD, Karolinska Institute.

Hugo Schmidt
Portfolio Manager – Healthcare Services

Employed at Rhenman & Partners since 2020. Education: B.Sc. Business & Economics, Stockholm School of Economics.

EN